Combination of fenretinide and selenite inhibits proliferation and induces apoptosis in ovarian cancer cells

International Journal of Molecular Sciences

Volumn 14, Issue 11, 2013, Pages 21790-21804

  Liu, Jie ^a   Li, Jia ^a   Zhang, Jian Fang ^a   Xin, Xiao Yan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Anti tumor effect; Combination; Fenretinide; Ovarian cancers cell; Selenite

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 9; CISPLATIN; CYTOCHROME C; FENRETINIDE; LACTATE DEHYDROGENASE; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; REACTIVE OXYGEN METABOLITE; SELENITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EXPOSURE; DRUG POTENTIATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VIVO STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; OVARY CANCER; PROTEIN EXPRESSION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; FEMALE; FENRETINIDE; HUMANS; OVARIAN NEOPLASMS; REACTIVE OXYGEN SPECIES; SELENIOUS ACID;

EID: 84887144321     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms141121790     Document Type: Article

References (51)

1. Assis, J.; Pereira, D.; Medeiros, R. Ovarian cancer and DNA repair: DNA ligase IV as a potential key. World J. Clin. Oncol. 2013, 4, 14-24.
2. Hojka-Osinska, A.; Ziolo, E.; Rapak, A. Combined treatment with fenretinide and indomethacin induces AIF-mediated, non-classical cell death in human acute T-cell leukemia Jurkat cells. Biochem. Biophys. Res. Commun. 2012, 419, 590-595.
3. Armstrong, J. L.; Martin, S.; Illingworth, N. A.; Jamieson, D.; Neilson, A.; Lovat, P. E.; Redfern, C. P.; Veal, G. J. The impact of retinoic acid treatment on the sensitivity of neuroblastoma cells to fenretinide. Oncol. Rep. 2012, 27, 293-298.
4. Kim, K. K.; Lange, T. S.; Singh, R. K.; Brard, L.; Moore, R. G. Tetrathiomolybdate sensitizes ovarian cancer cells to anticancer drugs doxorubicin, fenretinide, 5-fluorouracil and mitomycin C. BMC Cancer 2012, doi: 10. 1186/1471-2407-12-147.
5. Holpuch, A. S.; Phelps, M. P.; Desai, K. G.; Chen, W.; Koutras, G. M.; Han, B. B.; Warner, B. M.; Pei, P.; Seghi, G. A.; Tong, M.; et al. Evaluation of a mucoadhesive fenretinide patch for local intraoral delivery: A strategy to reintroduce fenretinide for oral cancer chemoprevention. Carcinogenesis 2012, 33, 1098-1105.
6. Pagnan, G.; Di-Paolo, D.; Carosio, R.; Pastorino, F.; Marimpietri, D.; Brignole, C.; Pezzolo, A.; Loi, M.; Galietta, L. J.; Piccardi, F.; et al. The combined therapeutic effects of bortezomib and fenretinide on neuroblastoma cells involve endoplasmic reticulum stress response. Clin. Cancer Res. 2009, 15, 1199-1209.
7. Zhang, H.; Mi, J. Q.; Fang, H.; Wang, Z.; Wang, C.; Wu, L.; Zhang, B.; Minden, M.; Yang, W. T.; Wang, H. W.; et al. Preferential eradication of acute myelogenous leukemia stem cells by fenretinide. Proc. Natl. Acad. Sci. USA 2013, 110, 5606-5611.
8. Yasuo, M.; Mizuno, S.; Allegood, J.; Kraskauskas, D.; Bogaard, H. J.; Spiegel, S.; Voelkel, N. F. Fenretinide causes emphysema, which is prevented by sphingosine 1-phoshate. PLoS One 2013, 8, e53927.
9. Kadara, H.; Tahara, E.; Kim, H. J.; Lotan, D.; Myers, J.; Lotan, R. Involvement of Rac in fenretinide-induced apoptosis. Cancer Res. 2008, 68, 4416-4423.
10. Ardekani, A. M.; Fard, S. S.; Jeddi-Tehrani, M.; Ghahremanzade, R. Bryostatin-1, fenretinide and 1α, 25 (OH)2D3 induce growth inhibition, apoptosis and differentiation in T and B Cell-derived acute lymphoblastic leukemia cell lines (CCRF-CEM and Nalm-6). Avicenna J. Med. Biotechnol. 2011, 3, 177-193.
11. Yang, H.; Bushue, N.; Bu, P.; Wan, Y. J. Inductionand intracellular localization of Nur77 dictate fenretinide-induced apoptosis of human liver cancer cells. Biochem. Pharmacol. 2010, 79, 948-954.
12. Raguénez, G.; Mühlethaler-Mottet, A.; Meier, R.; Duros, C.; Bénard, J.; Gross, N. Fenretinide-induced caspase-8 activation and apoptosis in an established model of metastatic neuroblastoma. BMC Cancer 2009, doi: 10. 1186/1471-2407-9-97.
13. Fang, H.; Harned, T. M.; Kalous, O.; Maldonado, V.; DeClerck, Y. A.; Reynolds, C. P. Synergistic activity of fenretinide and the Bcl-2 family protein inhibitor ABT-737 against human neuroblastoma. Clin. Cancer Res. 2011, 17, 7093-7104.
14. Holmes, W. F.; Soprano, D. R.; Soprano, K. J. Comparison of the mechanism of induction of apoptosis in ovarian carcinoma cells by the conformationally restricted synthetic retinoids CD437 and 4-HPR. J. Cell. Biochem. 2003, 89, 262-278.
15. Yang, H.; Zhan, Q.; Wan, Y. J. Enrichment of Nur77 mediated by retinoic acid receptor β leads to apoptosis of human hepatocellular carcinoma cells induced by fenretinide and histone deacetylase inhibitors. Hepatology 2011, 53, 865-874.
16. White, D. E.; Burchill, S. A. Fenretinide-dependent upregulation of death receptors through ASK1 and p38α enhances death receptor ligand-induced cell death in Ewing's sarcoma family of tumours. Br. J. Cancer 2010, 103, 1380-1390.
17. Koay, D. C.; Zerillo, C.; Narayan, M.; Harris, L. N.; DiGiovanna, M. P. Anti-tumor effects of retinoids combined with trastuzumab or tamoxifen in breast cancer cells: Induction of apoptosis by retinoid/trastuzumab combinations. Breast Cancer Res. 2010, doi: 10. 1186/bcr2625.
18. Cuperus, R.; Leen, R.; Tytgat, G. A.; Caron, H. N.; van Kuilenburg, A. B. Fenretinide induces mitochondrial ROS and inhibits the mitochondrial respiratory chain in neuroblastoma. Cell. Mol. Life Sci. 2010, 67, 807-816.
19. Park, S. H.; Kim, J. H.; Chi, G. Y.; Kim, G. Y.; Chang, Y. C.; Moon, S. K.; Nam, S. W.; Kim, W. J.; Yoo, Y. H.; Choi, Y. H. Induction of apoptosis and autophagy by sodium selenite in A549 human lung carcinoma cells through generation of reactive oxygen species. Toxicol. Lett. 2012, 212, 252-261.
20. Gowda, R.; Madhunapantula, S. V.; Desai, D.; Amin, S.; Robertson, G. P. Selenium-containing histone deacetylase inhibitors for melanoma management. Cancer Biol. Ther. 2012, 13, 756-765.
21. Kim, Y. W.; Bae, S. M.; Liu, H. B.; Kim, I. W.; Chun, H. J.; Ahn, W. S. Selenium enhances the efficacy of Radachlorin mediated-photodynamic therapy in TC-1 tumor development. Oncol. Rep. 2012, 28, 576-584.
22. Lei, M.; Chen, D.; Deng, X.; Liu, J.; Chen, L.; Liu, Y.; Li, B.; Yao, H.; Xiong, G.; Cao, Y.; et al. Dynamic sieving capillary electrophoresis analysis of xylitol selenite-induced apoptosis in SMMC-7221 cells. Biotechnol. Lett. 2012, 34, 1617-1621.
23. Huang, C.; Ding, G.; Gu, C.; Zhou, J.; Kuang, M.; Ji, Y.; He, Y.; Kondo, T.; Fan, J. Decreased selenium-binding protein 1 enhances glutathione peroxidase 1 activity and downregulates HIF-1α to promote hepatocellular carcinoma invasiveness. Clin. Cancer Res. 2012, 18, 3042-3053.
24. Yang, J.; Yang, X.; Fan, J.; Zhao, Q.; Xu, C. The novel selenium heteropoly compound (NH4)4H4[Se2Mo2V4O24]·7H2O induces apoptosis of K562 cells. Mol. Med. Rep. 2011, 4, 1327-1332.
25. Zhu, X.; Guo, K.; Lu, Y. Selenium effectively inhibits 1, 2-dihydroxynaphthalene-induced apoptosis in human lens epithelial cells through activation of PI3-K/Akt pathway. Mol. Vis. 2011, 17, 2019-2027.
26. Cassidy, P. B.; Fain, H. D.; Cassidy, J. P.; Tran, S. M.; Moos, P. J.; Boucher, K. M.; Gerads, R.; Florell, S. R.; Grossman, D.; Leachman, S. A. Selenium for the prevention of cutaneous melanoma. Nutrients 2013, 5, 725-749.
27. Kim, S. L.; Kim, S. H.; Trang, K. T.; Kim, I. H.; Lee, S. O.; Lee, S. T.; Kim, D. G.; Kang, S. B.; Kim, S. W. Synergistic antitumor effect of 5-fluorouracil in combination with parthenolide in human colorectal cancer. Cancer Lett. 2013, 335, 479-486.
28. Holmes, W. F.; Soprano, D. R.; Soprano, K. J. Synthetic retinoids as inducers of apoptosis in ovarian carcinoma cell lines. J. Cell. Physiol. 2004, 199, 317-329.
29. Chen, L.; Han, F.; Qu, H.; Yan, H.; Ren, L.; Yang, S. Combination therapy with 5-amino-4-imidazolecarboxamide riboside and arsenic trioxide in acute myeloid leukemia cells involving AMPK/TSC2/mTOR pathway. Pharmazie 2013, 68, 117-123.
30. Luo, H.; Yang, Y.; Duan, J.; Wu, P.; Jiang, Q.; Xu, C. PTEN-regulated AKT/FoxO3a/Bim signaling contributes to reactive oxygen species-mediated apoptosis in selenite-treated colorectal cancer cells. Cell Death Dis. 2013, doi: 10. 1038/cddis. 2013. 3.
31. He, N.; Shi, X.; Zhao, Y.; Tian, L.; Wang, D.; Yang, X. Inhibitory effects and molecular mechanisms of selenium-containing tea polysaccharides on human breast cancer MCF-7 cells. J. Agric. Food Chem. 2013, 61, 579-588.
32. Selvaraj, V.; Tomblin, J.; Yeager Armistead, M.; Murray, E. Selenium (sodium selenite) causes cytotoxicity and apoptotic mediated cell death in PLHC-1 fish cell line through DNA and mitochondrial membrane potential damage. Ecotoxicol. Environ. Saf. 2013, 87, 80-88.
33. Selvaraj, V.; Yeager-Armstead, M.; Murray, E. Protective and antioxidant role of selenium on arsenic trioxide-induced oxidative stress and genotoxicity in the fish hepatoma cell line PLHC-1. Environ. Toxicol. Chem. 2012, 31, 2861-2869.
34. Sanmartín, C.; Plano, D.; Sharma, A. K.; Palop, J. A. Selenium compounds, apoptosis and other types of cell death: An overview for cancer therapy. Int. J. Mol. Sci. 2012, 13, 9649-9572.
35. Zheng, S.; Li, X.; Zhang, Y.; Xie, Q.; Wong, Y. S.; Zheng, W.; Chen, T. PEG-nanolized ultrasmall selenium nanoparticles overcome drug resistance in hepatocellular carcinoma HepG2 cells through induction of mitochondria dysfunction. Int. J. Nanomed. 2012, 7, 3939-3949.
36. Liu, W.; Li, X.; Wong, Y. S.; Zheng, W.; Zhang, Y.; Cao, W.; Chen, T. Selenium nanoparticles as a carrier of 5-fluorouracil to achieve anticancer synergism. ACS Nano 2012, 6, 6578-6591.
37. Kong, L.; Yuan, Q.; Zhu, H.; Li, Y.; Guo, Q.; Wang, Q.; Bi, X.; Gao, X. The suppression of prostate LNCaP cancer cells growth by Selenium nanoparticles through Akt/Mdm2/AR controlled apoptosis. Biomaterials 2011, 32, 6515-6522.
38. Shang, D.; Li, Y.; Wang, C.; Wang, X.; Yu, Z.; Fu, X. A novel polysaccharide from Se-enriched Ganoderma lucidum induces apoptosis of human breast cancer cells. Oncol. Rep. 2011, 25, 267-272.
39. Wu, M.; Kang, M. M.; Schoene, N. W.; Cheng, W. H. Selenium compounds activate early barriers of tumorigenesis. J. Biol. Chem. 2010, 285, 12055-12062.
40. Abdulah, R.; Faried, A.; Kobayashi, K.; Yamazaki, C.; Suradji, E. W.; Ito, K.; Suzuki, K.; Murakami, M.; Kuwano, H.; Koyama, H. Selenium enrichment of broccoli sprout extract increases chemosensitivity and apoptosis of LNCaP prostate cancer cells. BMC Cancer 2009, doi: 10. 1186/1471-2407-9-414.
41. Uǧuz, A. C.; Naziroǧlu, M.; Espino, J.; Bejarano, I.; González, D.; Rodríguez, A. B.; Pariente, J. A. Selenium modulates oxidative stress-induced cell apoptosis in human myeloid HL-60 cells through regulation of calcium release and caspase-3 and-9 activities. J. Membr. Biol. 2009, 232, 15-23.
42. Das, A.; Bortner, J.; Desai, D.; Amin, S.; El-Bayoumy, K. The selenium analog of the chemopreventive compound S, S'-[1, 4-phenylenebis(1, 2-ethanediyl)] bisisothiourea is a remarkable inducer of apoptosis and inhibitor of cell growth in human non-small cell lung cancer. Chem. Biol. Interact. 2009, 180, 158-164.
43. Huang, F.; Nie, C.; Yang, Y.; Yue, W.; Ren, Y.; Shang, Y.; Wang, X.; Jin, H.; Xu, C.; Chen, Q. Selenite induces redox-dependent Bax activation and apoptosis in colorectal cancer cells. Free Radic. Biol. Med. 2009, 46, 1186-1196.
44. Yang, J. Y.; Xu, C. S. Antitumor effects of a selenium heteropoly complex in K562 cells. Pharmacol. Rep. 2009, 61, 288-295.
45. Gundimeda, U.; Schiffman, J. E.; Chhabra, D.; Wong, J.; Wu, A.; Gopalakrishna, R. Locally generated methylseleninic acid induces specific inactivation of protein kinase C isoenzymes: Relevance to selenium-induced apoptosis in prostate cancer cells. J. Biol. Chem. 2008, 283, 34519-34531.
46. Zuo, L.; Li, J.; Yang, Y.; Wang, X.; Shen, T.; Xu, C. M.; Zhang, Z. N. Sodium selenite induces apoptosis in acute promyelocytic leukemia-derived NB4 cells by a caspase-3-dependent mechanism and a redox pathway different from that of arsenic trioxide. Ann. Hematol. 2004, 83, 751-758.
47. Vander-Heiden, M. G.; Cantley, L. C.; Thompson, C. B. Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 2009, 324, 1029-1033.
48. Pérez-Sampietro, M.; Casas, C.; Herrero, E. The AMPK family member Snf1 protects Saccharomyces cerevisiae cells upon glutathione oxidation. PLoS One 2013, 8, e58283.
49. Fotakis, G.; Timbrell, J. A. In vitro cytotoxicity assays: Comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicol. Lett. 2006, 160, 171-177.
50. Mijatovic, S.; Maksimovic-Ivanic, D.; Radovic, J.; Miljkovic, D.; Kaludjerovic, G. N.; Sabo, T. J.; Trajkovic, V. Aloe emodin decreases the ERK-dependent anticancer activity of cisplatin. Cell. Mol. Life Sci. 2005, 62, 1275-1282.
51. Janjetovic, K.; Vucicevic, L.; Misirkic, M.; Vilimanovich, U.; Tovilovic, G.; Zogovic, N.; Nikolic, Z.; Jovanovic, S.; Bumbasirevic, V.; Trajkovic, V.; et al. Metformin reduces cisplatin-mediated apoptotic death of cancer cells through AMPK-independent activation of Akt. Eur. J. Pharmacol. 2011, 651, 41-50.